Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia

Oncogene

Volumn 29, Issue 13, 2010, Pages 1963-1975

  Yamasaki, N ^a   Miyazaki, K ^a   Nagamachi, A ^a   Koller, R ^b   Oda, H ^c   Miyazaki, M ^d   Sasaki, T ^a   Honda, Z I ^e   Wolff, L ^b   Inaba, T ^a   Honda, H ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

E2A HLF; Inducible knock in mice; Retrovirus insertional mutagenesis; Zfp521 ZNF521

Indexed keywords

UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 1A1; ZINC FINGER PROTEIN 521;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA EXTRACTION; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE REARRANGEMENT; GENOME; IMMUNOPRECIPITATION; INTRON; MOUSE; MUTAGENESIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNTRANSLATED REGION;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; HUMANS; MICE; MUTATION; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSCRIPTIONAL ACTIVATION;

MUS;

EID: 77950520441     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.475     Document Type: Article

References (43)

1. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG. (2004). RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 32: (Database issue) D523-527. (Pubitemid 38081713)
2. Aspland SE, Bendall HH, Murre C. (2001). The role of E2A-PBX1 in leukemogenesis. Oncogene 20: 5708-5717. (Pubitemid 32928108)
3. Bain G, Engel I, Robanus Maandag EC, te Riele HP, Voland JR, Sharp LL et al. (1997). E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol 17: 4782-4791. (Pubitemid 27318153)
4. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC et al. (1994). E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79: 885-892. (Pubitemid 24371978)
5. Beverly LJ, Capobianco AJ. (2003). Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis. Cancer Cell 3: 551-564.
6. Bond HM, Mesuraca M, Amodio N, Mega T, Agosti V, Fanello D et al. (2008). Early hematopoietic zinc finger protein-zinc finger protein 521: a candidate regulator of diverse immature cells. Int J Biochem Cell Biol 40: 848-854. (Pubitemid 351329659)
7. Dang J, Inukai T, Kurosawa H, Goi K, Inaba T, Lenny NT et al. (2001). The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1. Mol Cell Biol 21: 5935-5945. (Pubitemid 32737810)
8. Gilks CB, Bear SE, Grimes HL, Tsichlis PN. (1993). Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol 13: 1759-1768.
9. Hentges KE, Weiser KC, Schountz T, Woodward LS, Morse HC, Justice MJ. (2005). Evi3, a zinc-finger protein related to EBFAZ, regulates EBF activity in B-cell leukemia. Oncogene 24: 1220-1230. (Pubitemid 40313923)
10. Higuchi M, O'Brien D, Kumaravelu P, Lenny N, Yeoh EJ, Downing JR. (2002). Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 1: 63-74. (Pubitemid 41039177)
11. Honda H, Fujii T, Takatoku M, Mano H, Witte ON, Yazaki Y et al. (1995). Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood 85: 2853-2861.
12. Honda H, Inaba T, Suzuki T, Oda H, Ebihara Y, Tsuiji K et al. (1999). Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia. Blood 93: 2780-2790. (Pubitemid 29200767)
13. Hunger SP. (1996). Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood 87: 1211-1224.
14. Inaba T, Inukai T, Yoshihara T, Seyschab H, Ashmun RA, Canman CE et al. (1996). Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor. Nature 382: 541-544. (Pubitemid 26260696)
15. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD et al. (1992). Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257: 531-534.
16. Inukai T, Inaba T, Yoshihara T, Look AT. (1997). Cell transformation mediated by homodimeric E2A-HLF transcription factors. Mol Cell Biol 17: 1417-1424. (Pubitemid 27097370)
17. Inukai T, Inoue A, Kurosawa H, Goi K, Shinjyo T, Ozawa K et al. (1999). SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol Cell 4: 343-352. (Pubitemid 29499787)
18. Jonkers J, Berns A. (1996). Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochem Biophys Acta 1287: 29-57. (Pubitemid 26178311)
19. Kuhn R, Schwenk F, Aguet M, Rajewsky K. (1995). Inducible gene targeting in mice. Science 269: 1427-1429.
20. Kurosawa H, Goi K, Inukai T, Inaba T, Chang KS, Shinjyo T et al. (1999). Two candidate downstream target genes for E2A-HLF. Blood 93: 321-332. (Pubitemid 29019419)
21. Lin H, Grosschedl R. (1995). Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376: 263-267.
22. Look AT. (1997). Oncogenic transcription factors in the human acute leukemias. Science 278: 1059-1064. (Pubitemid 27517875)
23. Matsunaga T, Inaba T, Matsui H, Okuya M, Miyajima A, Inukai T et al. (2003). Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein. Blood 103: 3185-3191. (Pubitemid 38451697)
24. Mikkers H, Berns A. (2003). Retroviral insertional mutagenesis: tagging cancer pathways. Adv Cancer Res 88: 53-99. (Pubitemid 36343279)
25. Miyazaki K, Kawamoto T, Tanimoto K, Nishiyama M, Honda H, Kato Y. (2002). Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem 277: 47014-47021. (Pubitemid 36159208)
26. Miyazaki K, Yamasaki N, Oda H, Kuwata T, Kanno Y, Miyazaki M et al. (2009). Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia. Blood 113: 4702-4710.
27. Mizuno T, Yamasaki N, Miyazaki K, Tazaki T, Koller R, Oda H et al. (2008). Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ ABL transgenic mice. Oncogene 27: 3465-3474. (Pubitemid 351769317)
28. Nakamura T. (2005). Retroviral insertional mutagenesis identifies oncogene cooperation. Cancer Sci 96: 7-12. (Pubitemid 40310018)
29. Nakayama H, Ishimaru F, Avitah N, Sezaki N, Fujii N, Nakase K et al. (1999). Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. Cancer Res 59: 3931-3934. (Pubitemid 29393556)
30. Rosenbaum H, Harris AW, Bath ML, McNeall J, Webb E, Adams JM et al. (1990). An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene. EMBOJ 9: 897-905. (Pubitemid 20080626)
31. Scheijen B, Jonkers J, Acton D, Berns A. (1997). Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice. J Virol 71: 9-16. (Pubitemid 126424267)
32. Seidel MG, Look AT. (2001). E2A-HLF usurps control of evolutio-narily conserved survival pathways. Oncogene 20: 5718-5725.
33. Shinto Y, Morimoto M, Katsumata M, Uchida A, Aozasa K, Okamoto M et al. (1995). Moloneymurine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice. Oncogene 11: 1729-1736.
34. Smith KS, Rhee JW, Cleary ML. (2002). Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2. Mol Cell Biol 22: 7678-7687.
35. Smith KS, Rhee JW, Naumovski L, Cleary ML. (1999). Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice. Mol Cell Biol 19: 4443-4451. (Pubitemid 29242018)
36. Wang J, Iwasaki H, Krivtsov A, Febbo PG, Thorner AR, Ernst P et al. (2005). Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. EMBOJ 24: 368-381. (Pubitemid 40216141)
37. Warming S, Liu P, Suzuki T, Akagi K, Lindtner S, Pavlakis GN et al. (2003). Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Kruppel-like zinc finger protein. Blood 101: 1934-1940. (Pubitemid 36237596)
38. Wolff L, Garin MT, Koller R, Bies J, Liao W, Malumbres M et al. (2003a). Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice. Oncogene 22: 9265-9274. (Pubitemid 38122038)
39. Wolff L, Koller R, Hu X, Anver MR. (2003b). A Moloney murine leukemia virus-based retrovirus with 4070A long terminal repeat sequences induces a high incidence of myeloid as well as lymphoid neoplasms. J Virol 77: 4965-4971. (Pubitemid 36402845)
40. Yamashita N, Osato M, Huang L, Yanagida M, Kogan SC, Iwasaki M et al. (2005). Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice. Br J Haematol 131: 495-507. (Pubitemid 43899649)
41. Yoshihara T, Inaba T, Shapiro LH, Kato JY, Look AT. (1995). E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF. Mol Cell Biol 15: 3247-3255.
42. Zhuang Y, Soriano P, Weintraub H. (1994). The helix-loop-helix gene E2A is required for B cell formation. Cell 79: 875-884. (Pubitemid 24371977)
43. Zornig M, Schmidt T, Karsunky H, Grzeschiczek A, Moroy T. (1996). Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene 12: 1789-1801. (Pubitemid 26146304)